Literature DB >> 30233710

Effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after acute myocardial infarction.

Yingchun Zhang1, Lingzhi Zhang2, Hongzhi Zheng3, Hongfen Chen1.   

Abstract

The effects of atrial fibrillation on complications and prognosis of patients receiving emergency percutaneous coronary intervention after acute myocardial infarction (AMI) were investigated. Eighty AMI patients treated with interventional vascular recanalization in the Affiliated Hospital of Weifang Medical University (Weifang, China) from July 2015 to October 2016 were selected, including 40 patients complicated with atrial fibrillation before operation (control group) and 40 patients without atrial fibrillation before operation (observation group). The systolic blood pressure, diastolic blood pressure, heart rate, arrhythmia and common complications after MI were compared. Changes in the coronary artery thrombolysis in myocardial infarction (TIMI) flow grade and left ventricular ejection fraction (LVEF) of patients were also recorded. Moreover, changes in brain natriuretic peptide (BNP) levels were compared. The recovery time of myocardial enzyme and total troponin in both groups was recorded. The systolic and diastolic blood pressure in the observation group were significantly higher than those in the control group (p<0.05). During the intervention, the total proportion of patients with ventricular arrhythmia, atrial arrhythmia, atrioventricular block and sinus tachycardia in the observation group was significantly lower than that in the control group (p<0.05). The total proportion of common complications after MI in the observation group was obviously lower than that in the control group (p<0.05). Coronary artery TIMI flow grades and LVEFs in the observation group were obviously higher than those in the control group. BNP levels in the observation group were significantly lower than those in the control group. The recovery time of myocardial enzyme and total troponin in the observation group was significantly earlier than that in the control group. Atrial fibrillation has a certain negative effect on the circulatory function in patients with AMI after the interventional therapy, and the proportions of arrhythmia and complications in patients after MI are increased at the same time, so the postoperative recovery of patients is slow with many complications.

Entities:  

Keywords:  acute myocardial infarction; atrial fibrillation; complications; percutaneous coronary intervention

Year:  2018        PMID: 30233710      PMCID: PMC6143848          DOI: 10.3892/etm.2018.6640

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Atrial fibrillation is one of the most common arrhythmias in clinic. When patients are complicated with acute myocardial infarction (AMI), the risk of atrial fibrillation is even higher than 15% (1). Atrial fibrillation complications may lead to an increase in ventricular rate, further increasing the myocardial oxygen consumption, and aggravating myocardial ischemia and hypoxia (2). A large number of studies have confirmed (3–5) that atrial fibrillation is an independent risk factor for MI in patients with coronary heart disease. After coronary heart disease develops into AMI, the mortality rate of patients may be significantly increased if they are complicated with atrial fibrillation. At present, revascularization can be performed effectively via percutaneous coronary intervention (PCI) for AMI patients complicated with atrial fibrillation, ensuring the reperfusion of ischemic myocardium (6). However, there are few literature studies on the effect of atrial fibrillation (new-onset or complicated previously) on the prognosis of patients receiving PCI after MI. In order to fill in the above gap, effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after AMI were mainly investigated in this study.

Materials and methods

General data

A total of 80 AMI patients treated with interventional vascular recanalization in the Affiliated Hospital of Weifang Medical University (Weifang, China) from July 2015 to October 2016 were selected and received electrocardiogram examination when enrolled, including 40 patients complicated with atrial fibrillation before operation (control group) and 40 patients without atrial fibrillation before operation (observation group). The patients signed the informed consent when enrolled, and this study was approved by the Ethics Committee of the Affiliated Hospital of Weifang Medical University (Weifang, China). They were aged 40–60 years with a survival time of more than 1 year. Patients complicated with heart failure, definite primary myocardial disease before operation, severe pulmonary infection, mental illness, coagulation disorders, platelet dysfunction, systemic immune system disease, other arrhythmia before onset, and pregnant and/or breastfeeding patients were eliminated. In observation group, there were 40 patients without atrial fibrillation, including 21 males and 19 females. In terms of atrial fibrillation type, there were 35 cases of acute atrial fibrillation, and 5 cases of chronic atrial fibrillation. The implementation time of interventional treatment was 1–12 h with an average of 5.1±0.3 h. In the control group, there were 40 patients complicated with atrial fibrillation, including 20 males and 20 females. In terms of atrial fibrillation type, there were 34 cases of acute atrial fibrillation, and 6 cases of chronic atrial fibrillation. The implementation time of the interventional treatment was 1–12 h with an average of 5.0±0.3 h. There were no statistically significant differences in comparisons of sex, age, atrial fibrillation type and implementation time of the interventional treatment between the two groups (p>0.05).

Treatment methods

After admission, all patients received continuous electrocardiogram monitoring for 24 h, and dynamic electrocardiogram monitoring for 24 h. The onset time, duration, and predisposing factors of patients complicated with atrial fibrillation were recorded, and vital signs of patients at the onset were clear. Operation standards of PCI were as follows: After treatment, the stenosis rate of the remaining parts in the coronary lumen should be <20%, and coronary artery thrombolysis in myocardial infarction (TIMI) flow grade reaches grade 3. In perioperative PCI, 300 mg clopidogrel [NMPN J20130083, manufactured by Sanofi Winthrop Industrie (Floirac, France), subpackaged by Sanofi Pharmaceutical Co., Ltd. (Hangzhou, China)] was taken at a draught each time, followed by oral administration of 75 mg clopidogrel per day for 12 consecutive months after operation. At the same time, 300 mg aspirin was taken at a draught before operation, followed by oral administration of 100 mg aspirin/day after operation for a long term.

Observation indexes

The patients were followed up for 1 year. The systolic and diastolic blood pressure, heart rate, arrhythmia and common complications after MI were compared between the two groups at 1 month after intervention. Changes in coronary artery TIMI flow grade and left ventricular ejection fraction (LVEF) of patients before operation, immediately after operation, and at 3 months and 1 year after operation were also compared. Moreover, changes in the brain natriuretic peptide (BNP) levels before operation and at 1 week and 1 month after operation were compared. Finally, the recovery time of myocardial enzyme and total troponin in both groups were recorded.

Evaluation criteria

Coronary artery TIMI flow grade is divided into a total of 4 grades (grade 0–3) as follows: Grade 0, there is no blood flow or perfusion; grade 1, there is very little blood flow or perfusion, and contrast agent can be seen only in the occluded site; grade 2, there is partial blood flow or perfusion, and contrast agent can pass the occluded site and reach the distant end, but the filling rate is lower than normal; and grade 3, there is normal blood flow or perfusion. BNP was detected via micro-particle enzyme immunoassay, and its normal range is 0–38 pg/ml. Serum lactic dehydrogenase (LDH) was detected via velocity method, and its normal range is 100–240 U/l. Creatine kinase-MB (CK-MB) was detected via colorimetric method, and its normal range is 0–25 IU/l. The level of cardiac troponin (cTn), including cTnT, cTnI and cTnC, >1.0 µg/l was used as a critical value of diagnosis of AMI.

Statistical analysis

Statistical Product and Service Solutions (SPSS) 13.0 software (SPSS, Inc., Chicago, IL, USA) was used. Measurement data are presented as mean ± standard deviation (mean ± SD). t-test was used for the comparison of means between the two groups, and Chi-square test was used for the intergroup comparison of rates. P<0.05 was considered to indicate a statistically significant difference.

Results

Comparison of systolic and diastolic blood pressure as well as heart rate at 1 month after intervention between the two groups

At 1 month after intervention, the systolic and diastolic blood pressure in the observation group were significantly higher than those in the control group (p<0.05), but the heart rate was lower than that in the control group (p<0.05) (Table I).
Table I.

Comparison of systolic blood pressure, diastolic blood pressure and heart rate at 1 month after intervention between the two groups (mean ± SD).

GroupsSystolic blood pressure (mmHg)Diastolic blood pressure (mmHg)Heart rate (time/min)
Observation105.6±2.768.9±1.187.5±2.9
Control85.3±1.947.6±0.698.6±3.6
t-test38.888107.51315.186
P-value0.0010.0010.001

Comparison of arrhythmia between the two groups

During the intervention, the total proportion of patients with ventricular arrhythmia, atrial arrhythmia, atrioventricular block and sinus tachycardia in the observation group was significantly lower than that in the control group (p<0.05) (Table II).
Table II.

Comparison of arrhythmia between the two groups (n).

GroupsVentricular arrhythmiaAtrial arrhythmiaAtrioventricular blockSinus tachycardia
Observation  1  21  2
Control1013911
χ26.7468.2055.6005.878
P-value0.0090.0040.0180.015

Comparison of common complications after MI between the two groups

During the 1-year follow-up after operation, the total proportion of common complications after MI, such as ventricular aneurysm, cardiac rupture, mural thrombosis and syndromes after MI, in the observation group was obviously lower than that in the control group (p<0.05) (Table III).
Table III.

Comparison of common complications after MI between the two groups (n).

GroupsVentricular aneurysmCardiac ruptureMural thrombosisSyndromes after MITotal incidence rate
Observation2021  5 (12.5%)
Control617317 (42.5%)
χ29.028
P-value0.001

Changes in coronary artery TIMI blood flow grades of patients at different time-points before and after operation

There was no statistically significant difference in the coronary artery TIMI flow grade between the two groups before operation (grade 0.3±0.3 vs. 0.3±0.1, t=0.000, p>0.05) (Fig. 1). The coronary artery TIMI flow grades in the observation group immediately after operation, and at 3 months and 1 year after operation were grade (2.6±0.3), (2.3±0.3) and (2.1±0.2), respectively, which were significantly higher than those in the control group (grade 2.2±0.2, 2.0±0.2 and 1.7±0.1) (t=7.016, 5.262 and 11.314, p<0.05).
Figure 1.

Changes in coronary artery TIMI blood flow grades of patients at different time-points before and after operation. Coronary artery TIMI flow grades in the observation group immediately after operation, and at 3 months and 1 year after operation are obviously higher than those in the control group during the same period (p<0.05). TIMI, thrombolysis in myocardial infarction.

Changes in LVEFs of patients at different time-points before and after operation

There was no statistically significant difference in LVEF between the two groups before operation (32.5±1.5 vs. 32.6±1.5%, t=0.298, p=0.766 >0.05) (Fig. 2). LVEFs in the observation group immediately after operation, and at 3 months and 1 year after operation were (41.5±2.0, 56.1±2.6 and 61.1±2.7%), respectively, which were significantly higher than those in the control group (38.6±1.8, 49.7±2.0 and 53.5±2.6%) (t=6.816, 12.340 and 12.823, p<0.05).
Figure 2.

Changes in LVEFs of patients at different time-points before and after operation. LVEFs in the observation group immediately after operation, and at 3 months and 1 year after operation are obviously higher than those in the control group during the same period (p<0.05). LVEF, left ventricular ejection fraction.

Changes in BNP levels of patients at different time-points before and after operation

There was no statistically significant difference in the BNP level between the two groups before operation (1285.6±23.6 vs. 1286.5±23.5 mg/l, t=0.171, p=0.865 >0.05) (Fig. 3). The BNP levels in the observation group at 1 week and 1 month after operation were (356.6±15.1 and 113.2±5.1 mg/l), respectively, which were obviously lower than those in the control group (689.9±20.8 and 286.9±9.5 mg/l) (t=82.012 and 101.886, p<0.05).
Figure 3.

Changes in the BNP levels of patients at different time-points before and after operation. At 1 week and 1 month after operation, the BNP levels in the observation group are significantly lower than those in the control group during the same period (p<0.05). BNP, brain natriuretic peptide.

Comparison of recovery time of myocardial enzyme and total troponin between the two groups

The recovery time of myocardial enzyme and total troponin in the observation group was significantly earlier than that in thw control group (p<0.05) (Table IV).
Table IV.

Comparison of recovery time of myocardial enzyme and total troponin between the two groups (mean ± SD).

GroupsLDH (days)CK-MB (h)Total troponin (days)
Observation8.1±0.265.3±2.111.3±0.5
Control9.6±0.371.2±3.113.7±0.9
t-test26.3129.96614.743
P-value0.0010.0010.001

Discussion

Currently, the pathogenesis of AMI complicated with atrial fibrillation is not yet fully understood in clinic, among which sinoatrial node ischemia (7) and decreased electrical stability of myocardium (8) are common theories. In AMI patients complicated with atrial fibrillation, the lesion is often located in the right coronary artery, and the possible reason is that the obstruction of the right coronary artery is prone to cause sinoatrial hypofunction, affecting sinus rhythm (9). At the same time, the electrical stability of myocardium is decreased, leading to atrial fibrillation. If AMI patients are complicated with atrial fibrillation, the cardiac output may be further reduced, increasing ventricular rate, causing further imbalance between myocardial oxygen supply and demand, aggravating myocardial ischemia and hypoxia, and even expanding the infarct size, ultimately inducing and aggravating heart failure and even resulting in cardiac arrest in patients (10). Timely PCI is currently the most effective treatment method for AMI (11). At present, there is abundant literature worldwide mainly on research on prognosis of AMI patients complicated with atrial fibrillation, but literature on the effect of atrial fibrillation on PCI after AMI is scarce. In this study, AMI patients undergoing PCI were divided into the observation group (without atrial fibrillation) and the control group (complicated with atrial fibrillation) according to whether they were complicated with atrial fibrillation. All patients were followed up for 1 year. Comparisons of systolic and diastolic blood pressure as well as heart rate between the two groups at 1 month after intervention showed that systolic and diastolic blood pressure in the observation group were significantly higher than those in the control group, but the heart rate was lower than that in the control group, suggesting that the postoperative circulatory function of patients without atrial fibrillation is more stable with better recovery. In addition, the research on arrhythmia and common complications after MI in both groups showed that the proportion of patients with ventricular arrhythmia, atrial arrhythmia, atrioventricular block and sinus tachycardia in the observation group was significantly lower than that in control group, and the total proportion of common complications after MI, such as ventricular aneurysm, cardiac rupture, mural thrombosis and syndromes after MI, in the observation group was obviously lower than that in the control group, indicating that arrhythmia, ventricular aneurysm, cardiac rupture, mural thrombosis and syndromes after MI seldom occur in patients without atrial fibrillation receiving PCI after MI. At the same time, it was found during the follow-up that the coronary artery TIMI flow grades and LVEFs in the observation group immediately after operation, and at 3 months and 1 year after operation were obviously higher than those in the control group during the same period, and at 1 week and 1 month after operation, the BNP levels in the observation group were significantly lower than those in the control group during the same period, suggesting that in patients without atrial fibrillation, the effect of vascular recanalization is better. The maintenance time is longer, and postoperative LVEF can be recovered rapidly and effectively, thus reducing myocardial damage and improving prognosis of patients. Finally, the recovery time of myocardial enzyme and total troponin was compared between the two groups, and it was found that the recovery time of myocardial enzyme and total troponin in the observation group was significantly earlier than that in the control group, further proving that the postoperative recovery of patients without atrial fibrillation is quicker. Performing vascular recanalization in coronary artery in the early stage, and maintaining myocardial perfusion, thus quickly and effectively relieving myocardial ischemia and hypoxia (12) have important values in increasing and improving the sinoatrial node arterial blood supply and reducing postoperative complications in AMI patients. Once MI occurs in patients complicated with atrial fibrillation before operation, especially rapid atrial fibrillation (13), cardiac function is prone to decline significantly (14), thereby aggravating myocardial ischemia via positive feedback, and increasing infarct size (15). Although timely interventional vascular recanalization is effective, it is difficult to improve sinoatrial node function in a short time, especially for patients with chronic atrial fibrillation (16). The long-term atrial fibrillation may result in mural thrombus shedding after MI, thus causing thromboembolic disease (17). Meanwhile, atrial fibrillation complicated before operation may further reduce the cardiac function of patients, increase ventricular rate and myocardial oxygen consumption (18), and lead to hemodynamic disorders, thereby increasing myocardial infarct size (19), even inducing heart failure and aggravating myocardial damage (20). In conclusion, atrial fibrillation has a certain negative effect on circulatory function in patients with AMI after interventional therapy, and the proportions of arrhythmia and complications in patients after MI are increased at the same time, so the postoperative recovery of patients is slow and with many complications.
  20 in total

1.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

2.  Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Authors:  Gorav Batra; Leif Friberg; David Erlinge; Stefan James; Tomas Jernberg; Bodil Svennblad; Lars Wallentin; Jonas Oldgren
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2018-01-01

3.  Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy.

Authors:  Akshay Bagai; Tracy Y Wang; Shaun G Goodman; Harold N Fisher; Robert C Welsh; Jean-Pierre Dery; Xiang Zhang; Yajun E Zhu; Asim N Cheema; Payam Dehghani; Saleem A Kassam; John Ducas; Neil Brass; Hahn Hoe Kim; Anthony Fung; Erick Schampaert; Ata Ur Rehman Quraishi; Shamir R Mehta
Journal:  Int J Cardiol       Date:  2016-11-14       Impact factor: 4.164

4.  Atrial Fibrillation on Admission Is Related With Higher Mortality in ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Kyung-Kuk Hwang; Sang-Yong Eom; Sang Yeub Lee; Sang Min Kim; Myeong-Chan Cho; Young Jo Kim; Ki Bae Seung; Myung Ho Jeong; Jang-Whan Bae
Journal:  Int Heart J       Date:  2017-07-10       Impact factor: 1.862

5.  Peak troponin I level predicts new-onset atrial fibrillation in patients with myocardial infarction.

Authors:  Regayip Zehir; Ahmet I Tekkesin; Nahide Haykir; Yalcin Velibey; Edibe B Borklu; Ayca Gumusdag
Journal:  Clin Invest Med       Date:  2016-12-01       Impact factor: 0.825

6.  Unexpected evolution of a non-stenotic lesion in the left main coronary artery of a patient with non-ST-segment elevation myocardial infarction.

Authors:  Alexandru Florin Ispas; Lionel Mangin; Alexandru Paziuc; Loic Belle
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

7.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

Authors:  C Michael Gibson; Roxana Mehran; Christoph Bode; Jonathan Halperin; Freek W Verheugt; Peter Wildgoose; Mary Birmingham; Juliana Ianus; Paul Burton; Martin van Eickels; Serge Korjian; Yazan Daaboul; Gregory Y H Lip; Marc Cohen; Steen Husted; Eric D Peterson; Keith A Fox
Journal:  N Engl J Med       Date:  2016-11-14       Impact factor: 91.245

8.  Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland.

Authors:  Tuire Prami; Houssem Khanfir; Anna Deleskog; Pål Hasvold; Ville Kytö; Eeva Reissell; Juhani Airaksinen
Journal:  BMJ Open       Date:  2016-11-22       Impact factor: 2.692

Review 9.  Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies.

Authors:  Nabin Chaudhary; Pravesh Kumar Bundhun; He Yan
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

10.  Current Use of Oral Anticoagulants and Prognostic Analysis in Patients with Atrial Fibrillation Undergoing Coronary Stenting.

Authors:  Heng-Bo Zhai; Jun Liu; Zhi-Chao Dong; Dong-Xia Wang; Bo Zhang
Journal:  Chin Med J (Engl)       Date:  2017-06-20       Impact factor: 2.628

View more
  1 in total

1.  Possible implication of miR-142-3p in coronary microembolization induced myocardial injury via ATXN1L/HDAC3/NOL3 axis.

Authors:  Yuli Xu; Xiangwei Lv; Ruping Cai; Yanling Ren; Shirong He; Wei Zhang; Quanzhong Li; Xiheng Yang; Rixin Dai; Riming Wei; Qiang Su
Journal:  J Mol Med (Berl)       Date:  2022-04-12       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.